←RETURN TO 2026 IPO RADAR DECK (135 OFFERINGS)COHORT STANDING: #113 of 135
Verified SEC Filing/Calendar Year 2026
NASDAQHealth Care
$ETRA
RANGE-BOUND (-50% to +50%)

Electra Therapeutics

Legal Entity: Electra Therapeutics, Inc.

OFFER PRICE$15.00
CURRENT PRICE
$8.99
CUMULATIVE RETURN
-41.70%
PRICING DATE: 9/18/2026OFFLINE SNAPSHOT
SECTION 01 // FORENSIC TEARDOWN

The Seagull Executive Verdict

SURVIVAL RATING: CRATER
WHAT THE BUSINESS DOES

Utilizes laboratory-engineered antibodies to modulate immune responses for cancer and autoimmune disease treatment. Pre-revenue cash burn operation.

THE WALL STREET PITCH

Pioneer in targeted immunology with a highly versatile biological platform.

THE COLD REALITY

Broken IPO suffering severe multiple compression due to public market impatience with early-stage preclinical assets.

SECTION 02 // CAPITAL ALLOCATION

Capital Formation & Float Scarcity

FLAG: TREASURY GROWTH
Gross Proceeds
$349.5M
Cash extracted from market
Post-Money Value
$1.6B
Total company valuation
Public Float %
22%
Shares available to public
Secondary Share %
0%
Insider cash extraction
CAPITAL USE ANALYSIS

Proceeds directed to balance sheet and operations.

SECTION 03 // SUPPLY SHOCK AUDITOR

Insider Lock-Up Expiration

VC DUMP RISK: ELEVATED
Expiration Calendar Date
2027-03-17
144 DAYS REMAINING
Supply Shock Multiplier
3.5x
Float expansion ratio upon unlock
Lockup Duration
180 Days
Contractual restriction window
RESTRICTED INSTITUTIONAL HOLDERS & PRE-IPO INSIDERS
Venture Syndicate

Insiders hold locked shares subject to release on 2027-03-17.

SECTION 04 // SYNDICATE TELEMETRY

Underwriter Syndicate & Fee Extraction

SPREAD: 7.00%
Gross Underwriting Spread
7.00%
Standard Wall Street fee cut
Estimated Syndicate Take
$24.5M
Total fees stripped from deal
Fee Per Public Share
$1.26
Direct cut per share printed
LEAD BOOKRUNNERS & JOINT MANAGERS
Goldman SachsMorgan StanleyJ.P. MorganJefferiesBofA Securities
SECTION 05 // COHORT BENCHMARK

Sector Peer & Cohort Telemetry

RANK: #113 of 135
2026 Cohort Standing
#113 of 135
Out of 135 total 2026 IPO offerings
Sector Median Return
+21.64%
Health Care sector midpoint
Sector Win Rate
78%
% of peer IPOs trading in profit
PERFORMANCE VS PEERS

Electra Therapeutics is currently trading below the Health Care sector median of 21.64%. Across the entire 2026 calendar year cohort, only 78% of Health Care offerings have sustained a positive return above their initial offer price.

SECTION 06 // PRIMARY REGULATORY PROVENANCE

SEC Filings & Works Cited

SEC CIK: 0002088082
FORM 424B4 // FINAL PROSPECTUS

The legal contract codifying offer pricing, gross underwriting spread, and lock-up terms.

Available via SEC EDGAR Search
FORM S-1 / S-1A // REGISTRATION STATEMENT

Initial company disclosure detailing capitalization structure, risk factors, and financial statements.

ACCESS EDGAR ARCHIVE→
WORKS CITED (MLA 9TH EDITION)

Electra Therapeutics. "Form 424B4 Prospectus." U.S. Securities and Exchange Commission, 9/18/2026, www.sec.gov/edgar.

United States, Securities and Exchange Commission. “EDGAR System Search & Research Database.” SEC.gov, 2026, www.sec.gov/edgar/searchedgar/companysearch.

← EXPLORE FULL 2026 IPO DECKBACK TO TOP ↑
TELEMETRY
BITCOIN SPOT: $84,471 [▲ 0.42%]///GOLD SPOT: $4,321.20/oz [▲ 0.54%]///SILVER SPOT: $64.80/oz [▲ 1.25%]///S&P 500: 7,743.41 [▲ 0.51%]///U.S. DEBT: $40.07T [■ Treasury]///10Y YIELD: 5.18% [▲ 0.43%]///BITCOIN SPOT: $84,471 [▲ 0.42%]///GOLD SPOT: $4,321.20/oz [▲ 0.54%]///SILVER SPOT: $64.80/oz [▲ 1.25%]///S&P 500: 7,743.41 [▲ 0.51%]///U.S. DEBT: $40.07T [■ Treasury]///10Y YIELD: 5.18% [▲ 0.43%]///BITCOIN SPOT: $84,471 [▲ 0.42%]///GOLD SPOT: $4,321.20/oz [▲ 0.54%]///SILVER SPOT: $64.80/oz [▲ 1.25%]///S&P 500: 7,743.41 [▲ 0.51%]///U.S. DEBT: $40.07T [■ Treasury]///10Y YIELD: 5.18% [▲ 0.43%]///